BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15210761)

  • 1. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells.
    Seroogy CM; Soares L; Ranheim EA; Su L; Holness C; Bloom D; Fathman CG
    J Immunol; 2004 Jul; 173(1):79-85. PubMed ID: 15210761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells.
    Anandasabapathy N; Ford GS; Bloom D; Holness C; Paragas V; Seroogy C; Skrenta H; Hollenhorst M; Fathman CG; Soares L
    Immunity; 2003 Apr; 18(4):535-47. PubMed ID: 12705856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions.
    Schartner JM; Simonson WT; Wernimont SA; Nettenstrom LM; Huttenlocher A; Seroogy CM
    J Biol Chem; 2009 Dec; 284(50):34674-81. PubMed ID: 19833735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two isoforms of otubain 1 regulate T cell anergy via GRAIL.
    Soares L; Seroogy C; Skrenta H; Anandasabapathy N; Lovelace P; Chung CD; Engleman E; Fathman CG
    Nat Immunol; 2004 Jan; 5(1):45-54. PubMed ID: 14661020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype.
    MacKenzie DA; Schartner J; Lin J; Timmel A; Jennens-Clough M; Fathman CG; Seroogy CM
    J Biol Chem; 2007 Mar; 282(13):9696-9702. PubMed ID: 17259178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL.
    Sande OJ; Karim AF; Li Q; Ding X; Harding CV; Rojas RE; Boom WH
    J Immunol; 2016 Jan; 196(2):691-702. PubMed ID: 26667170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.
    Su LL; Iwai H; Lin JT; Fathman CG
    J Immunol; 2009 Jul; 183(1):438-44. PubMed ID: 19542455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRAIL and Otubain-1 are Related to T Cell Hyporesponsiveness during Trypanosoma cruzi Infection.
    Stempin CC; Rojas Marquez JD; Ana Y; Cerban FM
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005307. PubMed ID: 28114324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent superantigen exposure in vivo leads to highly suppressive CD4+CD25+ and CD4+CD25- T cells with anergic and suppressive genetic signatures.
    Schartner JM; Singh AM; Dahlberg PE; Nettenstrom L; Seroogy CM
    Clin Exp Immunol; 2009 Feb; 155(2):348-56. PubMed ID: 19040605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance.
    Kriegel MA; Rathinam C; Flavell RA
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16770-5. PubMed ID: 19805371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
    Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
    J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes.
    Su L; Lineberry N; Huh Y; Soares L; Fathman CG
    J Immunol; 2006 Dec; 177(11):7559-66. PubMed ID: 17114425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease.
    Mukai A; Iijima H; Hiyama S; Fujii H; Shinzaki S; Inoue T; Shiraishi E; Kawai S; Araki M; Hayashi Y; Kondo J; Mizushima T; Kanto T; Egawa S; Nishida T; Tsujii M; Takehara T
    J Gastroenterol; 2014 Dec; 49(12):1524-35. PubMed ID: 24356810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
    Nguyen TTT; Wang ZE; Shen L; Schroeder A; Eckalbar W; Weiss A
    J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33974042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy.
    Lineberry NB; Su LL; Lin JT; Coffey GP; Seroogy CM; Fathman CG
    J Immunol; 2008 Aug; 181(3):1622-6. PubMed ID: 18641297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of GRAIL is associated with remission of ulcerative colitis.
    Egawa S; Iijima H; Shinzaki S; Nakajima S; Wang J; Kondo J; Ishii S; Yoshio T; Irie T; Nishida T; Kakiuchi Y; Yasumaru M; Yoshihara H; Kanto T; Tsujii M; Tsuji S; Hayashi N
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G163-G169. PubMed ID: 18467499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation.
    Nurieva RI; Zheng S; Jin W; Chung Y; Zhang Y; Martinez GJ; Reynolds JM; Wang SL; Lin X; Sun SC; Lozano G; Dong C
    Immunity; 2010 May; 32(5):670-80. PubMed ID: 20493730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRAIL (gene related to anergy in lymphocytes) regulates cytoskeletal reorganization through ubiquitination and degradation of Arp2/3 subunit 5 and coronin 1A.
    Ichikawa D; Mizuno M; Yamamura T; Miyake S
    J Biol Chem; 2011 Dec; 286(50):43465-74. PubMed ID: 22016387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness.
    Whiting CC; Su LL; Lin JT; Fathman CG
    FEBS J; 2011 Jan; 278(1):47-58. PubMed ID: 21078124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.
    Sundstedt A; Sigvardsson M; Leanderson T; Hedlund G; Kalland T; Dohlsten M
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):979-84. PubMed ID: 8577772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.